Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-03-29

Clinical Trial Update: Zonisamide/Bupropion Effects on Switching to Electronic Cigarettes [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the effects of zonisamide combined with bupropion on switching to electronic cigarettes for smoking cessation; study completed with pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zonisamide/Bupropion (zonisamide + bupropion)

Snippet

Sponsor: Rose Research Center, LLC | Conditions: Smoking Cessation | Phase 3 | Status: COMPLETED | Results posted: 2022-03-29